论文部分内容阅读
目的探讨血脂康联合辛伐他汀治疗2型糖尿病血脂异常的临床疗效。方法对我院2009年1月～2010年1月收治的80例2型糖尿病合并高血脂症患者的资料进行观察,观察血脂康联合辛伐他汀治疗(观察组)2型糖尿病血脂异常的临床效果,并与同期采用单一血脂康治疗(对照组)的效果进行对比分析。结果观察组显效率明显高于对照组,组间比较(P<0.05)有统计学意义;80例患者治疗后血脂水平均有明显下降,但观察组TG水平较对照组下降明显,组间比较(P<0.05)有统计学意义;观察组治疗后FPC水平较对照组有明显降低,组间比较(P<0.05)有统计学意义。结论血脂康联合辛伐他汀治疗2型糖尿病血脂异常,可全面改善血脂、血糖,且不良反应较少,是2型糖尿病血脂异常治疗的首选方法。
Objective To investigate the clinical effects of Xuezhikang combined with simvastatin on type 2 diabetes with dyslipidemia. Methods The data of 80 patients with type 2 diabetes mellitus and hyperlipidemia treated in our hospital from January 2009 to January 2010 were observed and the clinical effects of Xuezhikang combined with simvastatin (observation group) on type 2 diabetes mellitus were observed. , And compared with the same period using a single Xuezhikang treatment (control group) the effect of comparative analysis. Results The apparent efficiency of the observation group was significantly higher than that of the control group (P <0.05). The blood lipid levels of the 80 patients were significantly decreased after treatment, but the TG level of the observation group decreased significantly compared with the control group. (P <0.05). The FPC level of the observation group was significantly lower than that of the control group after treatment, and there was significant difference between the two groups (P <0.05). Conclusion Xuezhikang combined with simvastatin treatment of type 2 diabetes, dyslipidemia, can improve blood lipids, blood glucose, and less adverse reactions, is the preferred method of treatment of type 2 diabetes dyslipidemia.